# Ryse Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ryse-health

- Industry: Healthcare IT
- Headquarters: Arlington, US
- Website: www.rysehealth.com
- Total disclosed funding: $13M
- Latest round: Series A (Dec 21, 2022)
- Investors on record: 5

## About

Based in Virginia, US, and founded in 2021 by Erin Kane, and Richard Gurley (CEO), Ryse Health LLC, aka Ryse Health, is a healthcare specialist firm focusing on solutions for type 2 diabetic patients. In March 2023, Ryse Health LLC raised USD 6.5 million in series A funding led by new investor Route 66 Ventures, with participation from returning investors W Health Ventures and Healthworx. 

The company provides clinical care solutions for patients with type 2 diabetes. The firm’s platform includes continuous glucose monitoring solutions and a streamlined mobile app that provide real-time insights into blood glucose level. Patients are also assisted by a healthcare team that comprises a diabetic specialist, a dietician, a behavioral health specialist, and a health coach both physically and virtually.

The company intends to use the funds raised in March 2023 to increase its team and expand its network of partners and customer base.

## Funding rounds

- Series A, Dec 21, 2022, $9.8M — Route 66 Ventures, Healthworx, W Health Ventures
- Seed, Apr 8, 2022, $3.4M — Healthworx, CareFirst BlueCross BlueShield, Lifebridge Health Inc, W Health Ventures

## Investors

- Healthworx (https://capitalatlas.ai/funds/healthworx) — Seed, Series A
- CareFirst BlueCross BlueShield — Seed
- Lifebridge Health Inc — Seed
- W Health Ventures (https://capitalatlas.ai/funds/w-health-ventures) — Seed, Series A
- Route 66 Ventures (https://capitalatlas.ai/funds/route-66-ventures) — Series A